Rhythm Pharmaceuticals (RYTM) News Today → Global crypto currency reset (41 major banks signed up) (From Stansberry Research) (Ad) Free RYTM Stock Alerts $43.76 +2.78 (+6.78%) (As of 05/3/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAnMed Rhythm on the River in Powdersville postponed: Here's what you need to knowmsn.com - May 3 at 2:26 PMCelebrate dance with ‘Rhythm and Joy': A Kathak choreography by Shovana Narayanmsn.com - May 2 at 7:13 PMRhythm and Roots Festival's founder, Chuck Wentworth, passes away at 72msn.com - May 2 at 2:12 PMCardiac Monitoring & Cardiac Rhythm Management Devices Market Worth $26.4 billion | MarketsandMarkets™finance.yahoo.com - May 2 at 2:12 PMRhythm Pharmaceuticals (NASDAQ:RYTM) Trading 5.5% Higher marketbeat.com - April 30 at 6:01 PMRhythm Pharmaceuticals (RYTM) Set to Announce Quarterly Earnings on Tuesdaymarketbeat.com - April 30 at 12:16 PM'Bigger than the music': Legendary producer of Rhythm & Roots Festival diesyahoo.com - April 30 at 7:50 AMRhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & Endocrinologyglobenewswire.com - April 29 at 6:30 PMRhythm Pharmaceuticals (NASDAQ:RYTM) Receives "Buy" Rating from Needham & Company LLCamericanbankingnews.com - April 28 at 4:14 AMRhythm Pharmaceuticals (NASDAQ:RYTM) Given Buy Rating at Needham & Company LLCmarketbeat.com - April 26 at 8:44 AMWedge Capital Management L L P NC Sells 28,213 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)marketbeat.com - April 25 at 7:47 AMRhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024globenewswire.com - April 24 at 4:01 PMFederated Hermes Inc. Reduces Stock Holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)marketbeat.com - April 19 at 8:27 AMRhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Cut to $52.00 by Analysts at Wells Fargo & Companymarketbeat.com - April 18 at 9:13 AMRhythm Pharmaceuticals Announces New Employment Inducement Grantsglobenewswire.com - April 16 at 4:01 PMMarket Sentiment Around Loss-Making Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)finance.yahoo.com - April 14 at 10:32 AMRhythm and Autism comes to Fertile Ground Festivalyahoo.com - April 11 at 12:32 PM5 Analysts Assess Rhythm Pharmaceuticals: What You Need To Knowmarkets.businessinsider.com - April 10 at 4:29 PMLee Brice coming to Rhythm City Casinomsn.com - April 10 at 11:29 AMHendersonville's 2024 Rhythm and Brews lineup announcedmsn.com - April 9 at 7:47 AMRising Chorus: Rachana Shah and Rhythm Wagholikar’s Anthem for Prime Minister Modimsn.com - April 8 at 7:51 AMSG Americas Securities LLC Decreases Stock Position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)marketbeat.com - April 8 at 4:09 AMVanguard Group Inc. Grows Holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)marketbeat.com - April 7 at 4:10 AMHeadbangers: Rhythm Royale - Official Battle of the Dancers & Season 3 Launch Trailermsn.com - April 4 at 2:32 PMRhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) CAO Christopher Paul German Sells 368 Sharesinsidertrades.com - April 4 at 7:09 AMRhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) CAO Sells $15,367.68 in Stockmarketbeat.com - April 3 at 9:46 PMRick Springfield to play Rhythm City in Julymsn.com - April 2 at 10:04 PMRhythm Pharmaceuticals (NASDAQ:RYTM) Shares Gap Down to $43.33marketbeat.com - April 1 at 12:44 PMRhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financingglobenewswire.com - April 1 at 8:00 AMAssenagon Asset Management S.A. Sells 105,654 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)marketbeat.com - March 29 at 5:16 AM7 Stocks That Will Drive the Weight Loss Drugs Market (RYTM)marketbeat.com - March 28 at 7:22 AMRhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific Agonistglobenewswire.com - March 25 at 8:00 AMInsider Selling: Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Insider Sells 18,235 Shares of Stockinsidertrades.com - March 23 at 8:48 AMWatch: Singing dog Nova with "voice of an angel" performs Rhythm of the Night at RSPCA Sheffield sheltermsn.com - March 23 at 4:22 AMBongee Bear and the Kingdom of Rhythm Streaming: Watch & Stream Online via Amazon Prime Videoyahoo.com - March 22 at 11:21 PMChief Technical Officer Joseph Shulman Sells 18,235 Shares of Rhythm Pharmaceuticals Inc (RYTM)finance.yahoo.com - March 22 at 11:21 PMRhythm City welcomes Banda Magueymsn.com - March 22 at 6:21 PMHunter C. Smith Sells 15,515 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Stockinsidertrades.com - March 20 at 7:08 AMRhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) CEO Sells $1,784,274.68 in Stockinsidertrades.com - March 20 at 6:16 AMInsider Sell: CFO Hunter Smith Sells 15,515 Shares of Rhythm Pharmaceuticals Inc (RYTM)finance.yahoo.com - March 20 at 5:19 AMInsider Sell: Chief Technical Officer Joseph Shulman Sells 15,515 Shares of Rhythm ...finance.yahoo.com - March 20 at 5:19 AMInsider Sell: Rhythm Pharmaceuticals Inc (RYTM) CEO David Meeker Disposes of 45,494 Sharesfinance.yahoo.com - March 20 at 5:19 AMInsider Selling: Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) CFO Sells 15,515 Shares of Stockmarketbeat.com - March 19 at 10:22 PMRhythm Pharmaceuticals (NASDAQ:RYTM) Shares Down 5.5% marketbeat.com - March 19 at 4:49 PMRhythm City, Davenport, will bloom with Gin Blossoms alt rockmsn.com - March 19 at 2:16 PMRYTM Dec 2024 40.000 putfinance.yahoo.com - March 16 at 8:37 AMRYTM Apr 2024 70.000 callfinance.yahoo.com - March 16 at 8:37 AMRYTM Jul 2024 22.500 putfinance.yahoo.com - March 16 at 1:46 AMHudson Bay Capital Management LP Takes Position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)marketbeat.com - March 15 at 7:17 AMRhythm Games With The Most Unique Gameplaymsn.com - March 15 at 5:37 AM Get Rhythm Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RYTM and its competitors with MarketBeat's FREE daily newsletter. Email Address Gold Mania (Ad)Former Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite). See his free reveal right here. RYTM Media Mentions By Week RYTM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RYTM News Sentiment▼0.020.40▲Average Medical News Sentiment RYTM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RYTM Articles This Week▼95▲RYTM Articles Average Week Get Rhythm Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RYTM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Indivior News Today Corcept Therapeutics News Today PTC Therapeutics News Today Dyne Therapeutics News Today Arvinas News Today MoonLake Immunotherapeutics News Today MorphoSys News Today Vera Therapeutics News Today Geron News Today Merus News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RYTM) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyUrgent Nvidia WarningAltimetryAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsUrgent alert: open this for a huge profit potentialTimothy SykesThe A.I. story nobody is telling you (Read ASAP)TradeSmithREAD THIS – If You Missed Out On The AI BoomBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rhythm Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
